GB1390467A - Vaccination method using temperature sensitive virus mutants - Google Patents

Vaccination method using temperature sensitive virus mutants

Info

Publication number
GB1390467A
GB1390467A GB1530773A GB1530773A GB1390467A GB 1390467 A GB1390467 A GB 1390467A GB 1530773 A GB1530773 A GB 1530773A GB 1530773 A GB1530773 A GB 1530773A GB 1390467 A GB1390467 A GB 1390467A
Authority
GB
United Kingdom
Prior art keywords
temperature
sensitive
temperature sensitive
cut
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1530773A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recherche et Industrie Therapeutiques
Original Assignee
Recherche et Industrie Therapeutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recherche et Industrie Therapeutiques filed Critical Recherche et Industrie Therapeutiques
Priority to GB1530773A priority Critical patent/GB1390467A/en
Priority to ZA00741441A priority patent/ZA741441B/xx
Priority to US44885074 priority patent/US3897549A/en
Priority to FR7410112A priority patent/FR2223004B1/fr
Priority to AU67086/74A priority patent/AU486997B2/en
Priority to BE142433A priority patent/BE812816A/xx
Priority to NL7404054A priority patent/NL7404054A/xx
Priority to JP49036567A priority patent/JPS6035327B2/ja
Priority to DE2415353A priority patent/DE2415353A1/de
Priority to CA196,323A priority patent/CA1021261A/en
Priority to HURE000548 priority patent/HU169253B/hu
Publication of GB1390467A publication Critical patent/GB1390467A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB1530773A 1973-03-30 1973-03-30 Vaccination method using temperature sensitive virus mutants Expired GB1390467A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB1530773A GB1390467A (en) 1973-03-30 1973-03-30 Vaccination method using temperature sensitive virus mutants
ZA00741441A ZA741441B (en) 1973-03-30 1974-03-05 Herpes simplex type 2 virus vaccine and method of production and use
US44885074 US3897549A (en) 1973-03-30 1974-03-07 Herpes simplex type 2 virus vaccine and method of production and use
FR7410112A FR2223004B1 (enExample) 1973-03-30 1974-03-25
AU67086/74A AU486997B2 (en) 1973-03-30 1974-03-25 Herpes simplex type 2 virus vaccine and method of production and use
BE142433A BE812816A (fr) 1973-03-30 1974-03-26 Vaccin contre le virus herpes simplex type 2 et procede pour saproduction et son utilisation
NL7404054A NL7404054A (enExample) 1973-03-30 1974-03-26
JP49036567A JPS6035327B2 (ja) 1973-03-30 1974-03-29 ウイルス性発疹用ワクチン
DE2415353A DE2415353A1 (de) 1973-03-30 1974-03-29 Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen
CA196,323A CA1021261A (en) 1973-03-30 1974-03-29 Herpes simplex type 2 virus vaccine and method of production and use
HURE000548 HU169253B (enExample) 1973-03-30 1974-03-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1530773A GB1390467A (en) 1973-03-30 1973-03-30 Vaccination method using temperature sensitive virus mutants

Publications (1)

Publication Number Publication Date
GB1390467A true GB1390467A (en) 1975-04-16

Family

ID=10056766

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1530773A Expired GB1390467A (en) 1973-03-30 1973-03-30 Vaccination method using temperature sensitive virus mutants

Country Status (10)

Country Link
US (1) US3897549A (enExample)
JP (1) JPS6035327B2 (enExample)
BE (1) BE812816A (enExample)
CA (1) CA1021261A (enExample)
DE (1) DE2415353A1 (enExample)
FR (1) FR2223004B1 (enExample)
GB (1) GB1390467A (enExample)
HU (1) HU169253B (enExample)
NL (1) NL7404054A (enExample)
ZA (1) ZA741441B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2251434C1 (ru) * 2004-03-19 2005-05-10 Государственное образовательное учреждение "Красноярская государственная медицинская академия Министерства здравоохранения РФ" Способ вакцинации против краснухи на крайнем севере
RU2271830C1 (ru) * 2004-07-12 2006-03-20 ГУ Научно-исследовательский институт медицинских проблем Севера СО РАМН Способ вакцинопрофилактики краснухи на крайнем севере
RU2303459C1 (ru) * 2005-12-05 2007-07-27 ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) Способ вакцинации детей против краснухи на крайнем севере

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US4618493A (en) * 1982-10-13 1986-10-21 Smithkline-Rit Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
US4714678A (en) * 1982-10-13 1987-12-22 Smithkline-Rit Temperature sensitive strain of bovine viral diarrhoea virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4848621A (enExample) * 1971-10-20 1973-07-10
DE2215728C3 (de) * 1972-03-30 1979-02-15 Stickl, Helmut, Prof. Dr.Med., 8033 Krailling Arzneimittel zur Behandlung von Herpes simplex

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2251434C1 (ru) * 2004-03-19 2005-05-10 Государственное образовательное учреждение "Красноярская государственная медицинская академия Министерства здравоохранения РФ" Способ вакцинации против краснухи на крайнем севере
RU2271830C1 (ru) * 2004-07-12 2006-03-20 ГУ Научно-исследовательский институт медицинских проблем Севера СО РАМН Способ вакцинопрофилактики краснухи на крайнем севере
RU2303459C1 (ru) * 2005-12-05 2007-07-27 ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) Способ вакцинации детей против краснухи на крайнем севере

Also Published As

Publication number Publication date
CA1021261A (en) 1977-11-22
FR2223004A1 (enExample) 1974-10-25
FR2223004B1 (enExample) 1978-01-06
HU169253B (enExample) 1976-10-28
ZA741441B (en) 1975-02-26
JPS6035327B2 (ja) 1985-08-14
DE2415353A1 (de) 1974-10-03
AU6708674A (en) 1975-09-25
DE2415353C2 (enExample) 1987-10-01
NL7404054A (enExample) 1974-10-02
US3897549A (en) 1975-07-29
JPS5029736A (enExample) 1975-03-25
BE812816A (fr) 1974-09-26

Similar Documents

Publication Publication Date Title
Ulmer et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants
IL132468A0 (en) A kit for inducing immune response against a tumor or a disease caused by an infection agent
GB1390467A (en) Vaccination method using temperature sensitive virus mutants
IL96893A0 (en) Vaccines against cancer and infectious diseases
NO972196L (no) Polynukleotidvaksine mot tuberkulose
GB1510100A (en) Vaccines
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
DK251890D0 (da) Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering
GB1292803A (en) Improvements relating to the production of antigens
IE38555B1 (en) Vaccine and method for its production
EP0259324A4 (en) Mastitis vaccine.
BE839306A (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
DE69332264D1 (de) Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe
GB1152607A (en) Antigenic Compositions
Coggins et al. Serological Comparison with Rabbit Antisera of Hog Cholera Virus and Bovine Virus Diarrhea Virus.
Morein et al. Vaccination against herpesvirus, fiction or reality
RU2005779C1 (ru) Штамм бактерий leptospira interrogans "рябухин" серогруппы icterohaemorrhagiae, серовара copenhageni, используемый для приготовления вакцины против лептоспироза
GB1234747A (en) Improvements in or relating to the protection of domestic animals against pathogenic organisms
DK306379A (da) Herpesvirusvaccine
de Pilar Antibodies for developing adolescents and children. Conclusions for vaccinations against rubella, measles, mumps, diphtheria and tetanus.).
GB1465345A (en) Equine infectious anemia vaccine
Wasinski et al. Effect of antibiotics on the immune response of pigs against erysipelas suum vaccinated against swine fever, erysipelas and colibacillosis.
FI833717A0 (fi) Foerfarande foer framstaellning av modifierade, virusbetingade diarrevirusar
GB1390468A (en) Herpes simplex type 2 virus vaccine and method of production and use
Badr Mouse immunization studies summary with Ovivac vaccine.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee